BAY 1135626
BAY 1135626 is a synthetic precursor to BAY 1129980, an Auristatin-based antibody-drug conjugate (ADC) targeting C4.4A (LYPD3) . This ADC is utilized in non-small cell lung cancer (NSCLC) research, with studies investigating its anti-tumor activity in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1404071-37-9
Smiles
C ([C@H] (NC ([C@@H] ([C@@H] (OC) [C@]1 (N (C (C[C@H] ([C@@H] (N (C ([C@@H] (NC ([C@@H] (N (CCCC (NNC (CCCCCN2C (=O) C=CC2=O) =O) =O) C) [C@H] (C) C) =O) C (C) C) =O) C) [C@H] (CC) C) OC) =O) CCC1) [H]) C) =O) C (N) =O) C=3C=4C (NC3) =CC=CC4
Molecular Formula
C55H86N10O11
Molecular Weight
1063.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
